Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) Rattus norvegicus (Rat) Recombinant protein

BRCAI; BRCC1; IRIS; PSCP; RNF53; Breast Cancer 1,Early Onset; RING finger protein 53

Add to Cart Distributors
Overview
Properties
  • Source Prokaryotic expression, Host E.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationNucleus. Chromosome.
  • Molecular Mass 58.5kDa, Accurate 56kDa(Analysis of differences refer to the manual)
  • Residues & TagsSer1579~Glu1811 (Accession # O54952) with N-terminal His and GST Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder, Purity > 95%
  • Isoelectric Point5.9
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) Packages (Simulation)
  • Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) Packages (Simulation)
  • RPB376Ra01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Sequence

Usage

Reconstitute in PBS or others.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • IN VITRO EFFECT OF RESVERATROL ON DNA METHYLATION AND BRCA1 EXPRESSION IN MCF-7 HUMAN BREAST CANCER CELLSPublication: 281344291

Recommend products